The reduction in miR-146a led to less-efficient inhibition of the target genes involved in the Toll-like receptor and cytokine signaling pathway (TRAF6, IRAK1), deregulation of which is possibly involved in the carcinogenesis including HCC. This evidence concerns the gene TRAF6 and hepatocellular carcinoma.